Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Exercise-induced changes of B-type natriuretic peptide uncover the unknown coronary artery disease in patients with chest pain and normal left ventricular systolic function.

Paraskevaidis IA, Tsougos E, Varounis C, Dagres N, Karatzas D, Parissis J, Kremastinos DT.

Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):72-8. doi: 10.1097/HJR.0b013e32833a4529.

PMID:
20485180
2.

Integration of B-type natriuretic peptide levels with clinical data and exercise testing for predicting coronary artery disease.

Wolber T, Maeder M, Weilenmann D, Duru F, Bluzaite I, Riesen W, Rickli H, Ammann P.

Am J Cardiol. 2006 Sep 15;98(6):764-7. Epub 2006 Jul 28.

PMID:
16950181
3.

B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.

Palazzuoli A, Caputo M, Fineschi M, Navarri R, Calabrò A, Cameli M, Campagna MS, Franci B, Pierli C, Nuti R, Maisel A.

Eur J Prev Cardiol. 2012 Jun;19(3):366-73. doi: 10.1177/1741826711406608. Epub 2011 Apr 4.

PMID:
21464097
4.

Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization.

Palazzuoli A, Poldermans D, Capobianco S, Giannotti G, Iovine F, Campagna MS, Calabrò A, Bagaglia S, Nuti R.

Coron Artery Dis. 2006 Aug;17(5):419-23.

PMID:
16845249
5.

Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function.

Kim BS, Lee HJ, Shin HS, Yoon JH, Lee HY, Kim BJ, Sung KC, Kang JH, Lee MH, Park JR.

Transl Res. 2006 Oct;148(4):188-95.

PMID:
17002921
6.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.

7.
8.

Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease.

Møller JE, Bergeron S, Jaffe A, Pellikka PA.

Int J Cardiol. 2008 Feb 29;124(2):204-10. Epub 2007 Apr 18.

PMID:
17442418
9.
10.

N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.

Weber M, Dill T, Arnold R, Rau M, Ekinci O, Müller KD, Berkovitsch A, Mitrovic V, Hamm C.

Am Heart J. 2004 Oct;148(4):612-20.

PMID:
15459591
11.
12.

Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.

Kwan G, Isakson SR, Beede J, Clopton P, Maisel AS, Fitzgerald RL.

J Am Coll Cardiol. 2007 Mar 20;49(11):1186-92. Epub 2007 Mar 6.

13.

B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.

Goyal BM, Sharma SM, Walia M.

Indian Heart J. 2014 Mar-Apr;66(2):183-7. doi: 10.1016/j.ihj.2013.12.015. Epub 2013 Dec 26.

14.

Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.

Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2007 Apr 15;99(8):1051-4. Epub 2007 Mar 6.

PMID:
17437726
15.

Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure.

Baldasseroni S, Mannucci E, Orso F, Di Serio C, Pratesi A, Bartoli N, Marella GA, Colombi C, Foschini A, Valoti P, Mossello E, Fumagalli S, Marchionni N, Tarantini F.

Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):292-9. doi: 10.1016/j.numecd.2011.03.012. Epub 2011 Oct 26.

PMID:
22032915
16.

N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.

Hong SN, Yoon NS, Ahn Y, Lim SY, Kim YS, Yun KH, Kang DK, Lee SH, Lee YS, Kim KH, Son IS, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Circ J. 2005 Dec;69(12):1472-6.

17.

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.

Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N; Christchurch Cardioendocrine Research Group; Australia-New Zealand Heart Failure Group.

J Am Coll Cardiol. 2006 Jan 3;47(1):52-60. Epub 2005 Dec 15.

18.

Detection of high-burden coronary artery disease by exercise-induced changes of the E/E' ratio.

Tsougos E, Paraskevaidis I, Dagres N, Varounis C, Panou F, Karatzas D, Trapali X, Iliodromitis E, Kremastinos DT.

Int J Cardiovasc Imaging. 2012 Mar;28(3):521-30. doi: 10.1007/s10554-011-9840-3. Epub 2011 Mar 11.

PMID:
21394613
19.

Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?

Joung B, Ha JW, Ko YG, Kang SM, Rim SJ, Jang Y, Chung N, Shim WH, Cho SY.

Am Heart J. 2005 Dec;150(6):1213-9.

PMID:
16338261
20.

N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.

Wolber T, Maeder M, Rickli H, Riesen W, Binggeli C, Duru F, Ammann P.

Eur J Clin Invest. 2007 Jan;37(1):18-25.

PMID:
17181563

Supplemental Content

Support Center